AKT1 and endometrial cancer: As a tumor suppressor, PTEN inhibits the activation of the cell’s pro-survival signaling pathway, phosphoinositide 3-kinase (PI3K)/AKT pathway, which is important in initiation and progression of endometrial cancer [104,105].